November 11, 2025 — Leads & Copy — Rashad Brown has been appointed Vice President, Manufacturing and Supply Chain at Rockwell Medical, Inc. (Nasdaq: RMTI), bringing over two decades of experience in manufacturing operations and supply chain optimization to the healthcare company.
In his new role, Brown will oversee manufacturing operations, procurement, warehouse management, and supply chain optimization. He previously held leadership positions at Abbott Laboratories, Fresenius Medical Care, and Hearing Lab Technology, managing large-scale teams and multi-million dollar budgets.
Mark Strobeck, Ph.D., President and CEO of Rockwell Medical, said that Brown’s expertise in operational efficiencies and lean manufacturing aligns with the company’s strategy to scale its manufacturing and commitment to operational excellence. Strobeck added that Brown’s leadership will be crucial in optimizing manufacturing processes, ensuring reliability for customers, and positioning the company for sustainable growth.
Brown’s achievements include driving gross margin improvements, increasing overall equipment effectiveness (OEE) through automation initiatives, and negotiating cost reductions and supply chain efficiencies.
Brown also brings extensive experience operating in FDA-regulated environments, with a track record of successful audit outcomes and disciplined quality execution. He is also a veteran, having served in the U.S. Army 7th Special Forces Group (Airborne).
Rockwell Medical (Nasdaq: RMTI) develops, manufactures, and distributes hemodialysis products for dialysis providers globally. The company’s mission is to provide high-quality products and customer service to dialysis clinics and patients with end-stage kidney disease. Rockwell Medical has been certified as a Great Place to Work® in 2023, 2024 and 2025, and named Fortune Best Workplaces in Manufacturing & Production™ in 2024 and 2025.
Rockwell Medical’s products are vital to patients with end-stage kidney disease, and the company is focused on long-term growth strategies that enhance its products, processes, and people.
Certain statements in the press release are forward-looking and subject to risks and uncertainties detailed in Rockwell Medical’s SEC filings.
For more information, visit www.rockwellmed.com.
Source: Rockwell Medical, Inc.
